Unexpected extensions of non-small-cell lung cancer diagnosed during surgery: revisiting exploratory thoracotomies and incomplete resections

OBJECTIVES Only patients with a complete resection of non-small-cell lung cancer (NSCLC) may expect long-term survival. Despite the recent progress in imaging and induction therapy, a thoracotomy may remain exploratory or with incomplete resection (R2). Our purpose was to revisit these situations. M...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Interactive cardiovascular and thoracic surgery 2013-05, Vol.16 (5), p.667-672
Hauptverfasser: Foucault, Christophe, Mordant, Pierre, Grand, Bertrand, Achour, Karima, Arame, Alex, Dujon, Antoine, Le Pimpec Barthes, Françoise, Riquet, Marc
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 672
container_issue 5
container_start_page 667
container_title Interactive cardiovascular and thoracic surgery
container_volume 16
creator Foucault, Christophe
Mordant, Pierre
Grand, Bertrand
Achour, Karima
Arame, Alex
Dujon, Antoine
Le Pimpec Barthes, Françoise
Riquet, Marc
description OBJECTIVES Only patients with a complete resection of non-small-cell lung cancer (NSCLC) may expect long-term survival. Despite the recent progress in imaging and induction therapy, a thoracotomy may remain exploratory or with incomplete resection (R2). Our purpose was to revisit these situations. METHODS A total of 5305 patients who underwent surgery for NSCLC between 1980 and 2009 were reviewed. We compared the epidemiology, pathology, causes and prognosis characteristics of exploratory thoracotomy (ET) and R2 resections. RESULTS ET and R2 resections were observed in 223 (4%) and 197 (4%) patients, respectively. The frequency of ET decreased with time, while the frequency of R2 resection remained almost stable. The indications for ET and R2 resections were not significantly different. In comparison with ET, R2 resections were characterized by a significantly higher frequency of induction therapy (22 vs 17%, P < 10−3), adenocarcinomas (49 vs 15%, P < 10−6), T1-T2 (53 vs 29%, P < 10−6) and N0-N1 extension (67 vs 42%, P = 10−6). R2 resections were also characterized by a higher rate of postoperative complications (19.1 vs 9.9%, P = 0.014), with no significant difference in postoperative mortality (6.9 vs 4.9%, P = non significant). R2 resections resulted in a higher 5-year survival compared with ET (11.1 vs 1.2%, P = 10−3). There was no long-term survivor after ET, except during the last decade. CONCLUSIONS ET and R2 remain unavoidable. In comparison with ET, R2 resection is associated with a higher rate of postoperative complications, but a higher long-term survival.
doi_str_mv 10.1093/icvts/ivs512
format Article
fullrecord <record><control><sourceid>proquest_TOX</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3630409</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/icvts/ivs512</oup_id><sourcerecordid>1338393813</sourcerecordid><originalsourceid>FETCH-LOGICAL-c416t-33caca49a89077cd89a651e41c45e0e4298d59153265f6dfdf946aeab19f05143</originalsourceid><addsrcrecordid>eNp9UbFuFDEQtRCIJAcdNXIHBUvs9XqzpkBCEYFIkdKQ2nLs2YuR11483lPuH_hofLlwgibVjGbevDd6j5A3nH3kTIlTbzcFT_0GJW-fkWMue9WodpDPD70SR-QE8SdjXDHBXpKjVohODKI_Jr9vItzPYAs4CvcFIvoUkaaRxhQbnEwIjYUQaFjimloTLWTqvFnHhPXELdnXOS55DXn7iWbYePRlN6u0IWVTUt7Sclc7m0qaPCA10VEfbZrmAAXqDVb9newr8mI0AeH1Y12Rm4uvP86_N1fX3y7Pv1w1tuN9aYSwxppOmUGxszPrBmV6yaHjtpPAoGvV4KTiUrS9HHs3ulF1vQFzy9XIJO_Einze887L7QTOQizZBD1nP5m81cl4_f8m-ju9ThstesG6avqKvH8kyOnXAlj05HFnk4mQFtRcVHeVGGpdkQ97qM0JMcN4kOFM7wLUDwHqfYAV_vbf1w7gv4lVwLs9IC3z01R_AEUyrDs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1338393813</pqid></control><display><type>article</type><title>Unexpected extensions of non-small-cell lung cancer diagnosed during surgery: revisiting exploratory thoracotomies and incomplete resections</title><source>Oxford Open</source><creator>Foucault, Christophe ; Mordant, Pierre ; Grand, Bertrand ; Achour, Karima ; Arame, Alex ; Dujon, Antoine ; Le Pimpec Barthes, Françoise ; Riquet, Marc</creator><creatorcontrib>Foucault, Christophe ; Mordant, Pierre ; Grand, Bertrand ; Achour, Karima ; Arame, Alex ; Dujon, Antoine ; Le Pimpec Barthes, Françoise ; Riquet, Marc</creatorcontrib><description>OBJECTIVES Only patients with a complete resection of non-small-cell lung cancer (NSCLC) may expect long-term survival. Despite the recent progress in imaging and induction therapy, a thoracotomy may remain exploratory or with incomplete resection (R2). Our purpose was to revisit these situations. METHODS A total of 5305 patients who underwent surgery for NSCLC between 1980 and 2009 were reviewed. We compared the epidemiology, pathology, causes and prognosis characteristics of exploratory thoracotomy (ET) and R2 resections. RESULTS ET and R2 resections were observed in 223 (4%) and 197 (4%) patients, respectively. The frequency of ET decreased with time, while the frequency of R2 resection remained almost stable. The indications for ET and R2 resections were not significantly different. In comparison with ET, R2 resections were characterized by a significantly higher frequency of induction therapy (22 vs 17%, P &lt; 10−3), adenocarcinomas (49 vs 15%, P &lt; 10−6), T1-T2 (53 vs 29%, P &lt; 10−6) and N0-N1 extension (67 vs 42%, P = 10−6). R2 resections were also characterized by a higher rate of postoperative complications (19.1 vs 9.9%, P = 0.014), with no significant difference in postoperative mortality (6.9 vs 4.9%, P = non significant). R2 resections resulted in a higher 5-year survival compared with ET (11.1 vs 1.2%, P = 10−3). There was no long-term survivor after ET, except during the last decade. CONCLUSIONS ET and R2 remain unavoidable. In comparison with ET, R2 resection is associated with a higher rate of postoperative complications, but a higher long-term survival.</description><identifier>ISSN: 1569-9293</identifier><identifier>EISSN: 1569-9285</identifier><identifier>DOI: 10.1093/icvts/ivs512</identifier><identifier>PMID: 23343836</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Aged ; Carcinoma, Non-Small-Cell Lung - mortality ; Carcinoma, Non-Small-Cell Lung - secondary ; Carcinoma, Non-Small-Cell Lung - surgery ; Female ; France ; Humans ; Intraoperative Period ; Kaplan-Meier Estimate ; Lung Neoplasms - mortality ; Lung Neoplasms - pathology ; Lung Neoplasms - surgery ; Male ; Middle Aged ; Neoplasm, Residual ; Original ; Pneumonectomy - adverse effects ; Pneumonectomy - mortality ; Retrospective Studies ; Risk Factors ; Thoracotomy - adverse effects ; Thoracotomy - mortality ; Time Factors ; Treatment Outcome</subject><ispartof>Interactive cardiovascular and thoracic surgery, 2013-05, Vol.16 (5), p.667-672</ispartof><rights>The Author 2013. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved. 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c416t-33caca49a89077cd89a651e41c45e0e4298d59153265f6dfdf946aeab19f05143</citedby><cites>FETCH-LOGICAL-c416t-33caca49a89077cd89a651e41c45e0e4298d59153265f6dfdf946aeab19f05143</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3630409/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3630409/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,1603,27922,27923,53789,53791</link.rule.ids><linktorsrc>$$Uhttps://dx.doi.org/10.1093/icvts/ivs512$$EView_record_in_Oxford_University_Press$$FView_record_in_$$GOxford_University_Press</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23343836$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Foucault, Christophe</creatorcontrib><creatorcontrib>Mordant, Pierre</creatorcontrib><creatorcontrib>Grand, Bertrand</creatorcontrib><creatorcontrib>Achour, Karima</creatorcontrib><creatorcontrib>Arame, Alex</creatorcontrib><creatorcontrib>Dujon, Antoine</creatorcontrib><creatorcontrib>Le Pimpec Barthes, Françoise</creatorcontrib><creatorcontrib>Riquet, Marc</creatorcontrib><title>Unexpected extensions of non-small-cell lung cancer diagnosed during surgery: revisiting exploratory thoracotomies and incomplete resections</title><title>Interactive cardiovascular and thoracic surgery</title><addtitle>Interact Cardiovasc Thorac Surg</addtitle><description>OBJECTIVES Only patients with a complete resection of non-small-cell lung cancer (NSCLC) may expect long-term survival. Despite the recent progress in imaging and induction therapy, a thoracotomy may remain exploratory or with incomplete resection (R2). Our purpose was to revisit these situations. METHODS A total of 5305 patients who underwent surgery for NSCLC between 1980 and 2009 were reviewed. We compared the epidemiology, pathology, causes and prognosis characteristics of exploratory thoracotomy (ET) and R2 resections. RESULTS ET and R2 resections were observed in 223 (4%) and 197 (4%) patients, respectively. The frequency of ET decreased with time, while the frequency of R2 resection remained almost stable. The indications for ET and R2 resections were not significantly different. In comparison with ET, R2 resections were characterized by a significantly higher frequency of induction therapy (22 vs 17%, P &lt; 10−3), adenocarcinomas (49 vs 15%, P &lt; 10−6), T1-T2 (53 vs 29%, P &lt; 10−6) and N0-N1 extension (67 vs 42%, P = 10−6). R2 resections were also characterized by a higher rate of postoperative complications (19.1 vs 9.9%, P = 0.014), with no significant difference in postoperative mortality (6.9 vs 4.9%, P = non significant). R2 resections resulted in a higher 5-year survival compared with ET (11.1 vs 1.2%, P = 10−3). There was no long-term survivor after ET, except during the last decade. CONCLUSIONS ET and R2 remain unavoidable. In comparison with ET, R2 resection is associated with a higher rate of postoperative complications, but a higher long-term survival.</description><subject>Aged</subject><subject>Carcinoma, Non-Small-Cell Lung - mortality</subject><subject>Carcinoma, Non-Small-Cell Lung - secondary</subject><subject>Carcinoma, Non-Small-Cell Lung - surgery</subject><subject>Female</subject><subject>France</subject><subject>Humans</subject><subject>Intraoperative Period</subject><subject>Kaplan-Meier Estimate</subject><subject>Lung Neoplasms - mortality</subject><subject>Lung Neoplasms - pathology</subject><subject>Lung Neoplasms - surgery</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm, Residual</subject><subject>Original</subject><subject>Pneumonectomy - adverse effects</subject><subject>Pneumonectomy - mortality</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Thoracotomy - adverse effects</subject><subject>Thoracotomy - mortality</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>1569-9293</issn><issn>1569-9285</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UbFuFDEQtRCIJAcdNXIHBUvs9XqzpkBCEYFIkdKQ2nLs2YuR11483lPuH_hofLlwgibVjGbevDd6j5A3nH3kTIlTbzcFT_0GJW-fkWMue9WodpDPD70SR-QE8SdjXDHBXpKjVohODKI_Jr9vItzPYAs4CvcFIvoUkaaRxhQbnEwIjYUQaFjimloTLWTqvFnHhPXELdnXOS55DXn7iWbYePRlN6u0IWVTUt7Sclc7m0qaPCA10VEfbZrmAAXqDVb9newr8mI0AeH1Y12Rm4uvP86_N1fX3y7Pv1w1tuN9aYSwxppOmUGxszPrBmV6yaHjtpPAoGvV4KTiUrS9HHs3ulF1vQFzy9XIJO_Einze887L7QTOQizZBD1nP5m81cl4_f8m-ju9ThstesG6avqKvH8kyOnXAlj05HFnk4mQFtRcVHeVGGpdkQ97qM0JMcN4kOFM7wLUDwHqfYAV_vbf1w7gv4lVwLs9IC3z01R_AEUyrDs</recordid><startdate>20130501</startdate><enddate>20130501</enddate><creator>Foucault, Christophe</creator><creator>Mordant, Pierre</creator><creator>Grand, Bertrand</creator><creator>Achour, Karima</creator><creator>Arame, Alex</creator><creator>Dujon, Antoine</creator><creator>Le Pimpec Barthes, Françoise</creator><creator>Riquet, Marc</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20130501</creationdate><title>Unexpected extensions of non-small-cell lung cancer diagnosed during surgery: revisiting exploratory thoracotomies and incomplete resections</title><author>Foucault, Christophe ; Mordant, Pierre ; Grand, Bertrand ; Achour, Karima ; Arame, Alex ; Dujon, Antoine ; Le Pimpec Barthes, Françoise ; Riquet, Marc</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c416t-33caca49a89077cd89a651e41c45e0e4298d59153265f6dfdf946aeab19f05143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Aged</topic><topic>Carcinoma, Non-Small-Cell Lung - mortality</topic><topic>Carcinoma, Non-Small-Cell Lung - secondary</topic><topic>Carcinoma, Non-Small-Cell Lung - surgery</topic><topic>Female</topic><topic>France</topic><topic>Humans</topic><topic>Intraoperative Period</topic><topic>Kaplan-Meier Estimate</topic><topic>Lung Neoplasms - mortality</topic><topic>Lung Neoplasms - pathology</topic><topic>Lung Neoplasms - surgery</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm, Residual</topic><topic>Original</topic><topic>Pneumonectomy - adverse effects</topic><topic>Pneumonectomy - mortality</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Thoracotomy - adverse effects</topic><topic>Thoracotomy - mortality</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Foucault, Christophe</creatorcontrib><creatorcontrib>Mordant, Pierre</creatorcontrib><creatorcontrib>Grand, Bertrand</creatorcontrib><creatorcontrib>Achour, Karima</creatorcontrib><creatorcontrib>Arame, Alex</creatorcontrib><creatorcontrib>Dujon, Antoine</creatorcontrib><creatorcontrib>Le Pimpec Barthes, Françoise</creatorcontrib><creatorcontrib>Riquet, Marc</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Interactive cardiovascular and thoracic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Foucault, Christophe</au><au>Mordant, Pierre</au><au>Grand, Bertrand</au><au>Achour, Karima</au><au>Arame, Alex</au><au>Dujon, Antoine</au><au>Le Pimpec Barthes, Françoise</au><au>Riquet, Marc</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Unexpected extensions of non-small-cell lung cancer diagnosed during surgery: revisiting exploratory thoracotomies and incomplete resections</atitle><jtitle>Interactive cardiovascular and thoracic surgery</jtitle><addtitle>Interact Cardiovasc Thorac Surg</addtitle><date>2013-05-01</date><risdate>2013</risdate><volume>16</volume><issue>5</issue><spage>667</spage><epage>672</epage><pages>667-672</pages><issn>1569-9293</issn><eissn>1569-9285</eissn><abstract>OBJECTIVES Only patients with a complete resection of non-small-cell lung cancer (NSCLC) may expect long-term survival. Despite the recent progress in imaging and induction therapy, a thoracotomy may remain exploratory or with incomplete resection (R2). Our purpose was to revisit these situations. METHODS A total of 5305 patients who underwent surgery for NSCLC between 1980 and 2009 were reviewed. We compared the epidemiology, pathology, causes and prognosis characteristics of exploratory thoracotomy (ET) and R2 resections. RESULTS ET and R2 resections were observed in 223 (4%) and 197 (4%) patients, respectively. The frequency of ET decreased with time, while the frequency of R2 resection remained almost stable. The indications for ET and R2 resections were not significantly different. In comparison with ET, R2 resections were characterized by a significantly higher frequency of induction therapy (22 vs 17%, P &lt; 10−3), adenocarcinomas (49 vs 15%, P &lt; 10−6), T1-T2 (53 vs 29%, P &lt; 10−6) and N0-N1 extension (67 vs 42%, P = 10−6). R2 resections were also characterized by a higher rate of postoperative complications (19.1 vs 9.9%, P = 0.014), with no significant difference in postoperative mortality (6.9 vs 4.9%, P = non significant). R2 resections resulted in a higher 5-year survival compared with ET (11.1 vs 1.2%, P = 10−3). There was no long-term survivor after ET, except during the last decade. CONCLUSIONS ET and R2 remain unavoidable. In comparison with ET, R2 resection is associated with a higher rate of postoperative complications, but a higher long-term survival.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>23343836</pmid><doi>10.1093/icvts/ivs512</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 1569-9293
ispartof Interactive cardiovascular and thoracic surgery, 2013-05, Vol.16 (5), p.667-672
issn 1569-9293
1569-9285
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3630409
source Oxford Open
subjects Aged
Carcinoma, Non-Small-Cell Lung - mortality
Carcinoma, Non-Small-Cell Lung - secondary
Carcinoma, Non-Small-Cell Lung - surgery
Female
France
Humans
Intraoperative Period
Kaplan-Meier Estimate
Lung Neoplasms - mortality
Lung Neoplasms - pathology
Lung Neoplasms - surgery
Male
Middle Aged
Neoplasm, Residual
Original
Pneumonectomy - adverse effects
Pneumonectomy - mortality
Retrospective Studies
Risk Factors
Thoracotomy - adverse effects
Thoracotomy - mortality
Time Factors
Treatment Outcome
title Unexpected extensions of non-small-cell lung cancer diagnosed during surgery: revisiting exploratory thoracotomies and incomplete resections
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T16%3A47%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_TOX&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Unexpected%20extensions%20of%20non-small-cell%20lung%20cancer%20diagnosed%20during%20surgery:%20revisiting%20exploratory%20thoracotomies%20and%20incomplete%20resections&rft.jtitle=Interactive%20cardiovascular%20and%20thoracic%20surgery&rft.au=Foucault,%20Christophe&rft.date=2013-05-01&rft.volume=16&rft.issue=5&rft.spage=667&rft.epage=672&rft.pages=667-672&rft.issn=1569-9293&rft.eissn=1569-9285&rft_id=info:doi/10.1093/icvts/ivs512&rft_dat=%3Cproquest_TOX%3E1338393813%3C/proquest_TOX%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1338393813&rft_id=info:pmid/23343836&rft_oup_id=10.1093/icvts/ivs512&rfr_iscdi=true